New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2014
07:16 EDTAGNAllergan price target raised to $107 from $83 at Piper Jaffray
Piper Jaffray raised its price target for Allergan (AGN) shares to $107 citing the issuance of patents on Restasis. Piper believes the recent valuation expansion of shares is justified but thinks additional expansion is unlikely given the paragraph IV litigation versus Actavis (ACT). The firm reiterates a Neutral rating on Allergan.
News For AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 23, 2015
16:14 EDTAGNPershing Square liquidates stake in Allergan
Subscribe for More Information
09:03 EDTAGNLeerink analysts hold a meeting with a conference call hookup
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use